ReBOSSIS QDS is a cotton-like synthetic, resorbable bone void filler. It is composite material consisting of beta-tricalcium phosphate, siloxane-containing vaterite (a form of calcium…
ReBOSSIS QDS is a cotton-like synthetic, resorbable bone void filler. It is composite material consisting of beta-tricalcium phosphate, siloxane-containing vaterite (a form of calcium carbonate), and poly(L-lactide co glycolide). The electrospinning process used in manufacturing ReBOSSIS QDS results in a cotton-like physical form. Due to its physical form, ReBOSSIS QDS is flexible and can easily fill defects in appropriate amounts.
Who Else Makes It
Concentrated in Shanghai (1), Beijing (1).
Record
Regulatory record for ReBOSSIS QDS | Listed by | Orthorebirth Co., Ltd., Japan |
| FDA product code | MQV |
| Device type | Filler, Bone Void, Calcium Compound |
| Device class | Class 2 |
| Regulation | 21 CFR 888.3045 |
| Establishment | Specification developer, Manufacturer, Exporter |
| Record published | 2018-05-30 |
| Record revised | 2024-03-25 (version 4) |
Specifications
Specifications | MRI safety | Labeling does not contain MRI Safety Information |
| Supplied sterile | Yes |
| Single use | Yes |
| Prescription | Prescription only |
| Label carries | lot or batch number, expiry date |
| Storage | Storage environment temperature up to 25 °C; Special storage condition: Store in a dry place |
| Sizes | Total volume 2 to 4 ml |
| Distribution end date | 2019-10-31 |
Recalls
2 of these are Class II. Class II means a temporary or reversible health consequence. Volume alone is not a quality signal: a manufacturer that ships more recalls more.
Source: U.S. FDA establishment registration and device listing records, public domain. Restructured for clarity and searchability. Not affiliated with or endorsed by the FDA. Records are records: nothing here is an offer of sale.